Andreas Hartkopf

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Andreas Hartkopf

May 8, 2025, 09:59 | Insight

Elia Seguí: Can some early HER2+ BC be treated without chemotherapy

Elia Seguí, Predoctoral Researcher at Translational Genomics and Targeted therapies in Solid Tumors at August…

Feb 14, 2025, 08:43 | Science

Characteristics and prognosis of primary metastatic vs. recurrent HER2-, HR+ advanced breast cancer

A paper by Christina Walter et al. was published in The Breast Journal, titled: "Characteristics…

Feb 4, 2025, 15:30 | Insight

Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the Breast Cancer Research Digest - a…

All: 3 Posts: 1 - 100

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dato' Dr Saunthari Somasundaram: I’m deeply honored to be elected as the next President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

'

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023